Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004202
Status:
COMPLETED
Last Update Posted:
2021-08-26
First Post:
2000-01-21
Brief Title:
Combination Chemotherapy Radiation Therapy and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer
Sponsor:
Spectrum Pharmaceuticals Inc
Organization:
Spectrum Pharmaceuticals Inc
Organization Data
Organization:
Spectrum Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
CDR0000067445
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spectrum Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None